Sunil Kumar Manna

Sunil Kumar Manna (27 August 1968) is an Indian immunologist and the head of the immunology lab of the Centre for DNA Fingerprinting and Diagnostics. He is known for his studies on cell signaling and apoptosis. The Department of Biotechnology of the Government of India awarded him the National Bioscience Award for Career Development, one of the highest Indian science awards, for his contributions to biosciences, in 2009.

Sunil Kumar Manna
Born (1968-08-27) 27 August 1968
West Bengal, India
NationalityIndian
Alma mater
Known forStudies on apoptosis in cancer
Awards
Scientific career
Fields
Institutions
Doctoral advisor

Biography

Sunil Kumar Manna, born on 27 August 1968, pursued his post-graduate education at the University of Calcutta and after earning an MSc, he did his doctoral research at the Indian Institute of Chemical Biology which secured him a PhD from Jadavpur University.[1] His post-doctoral work was at the University of Texas MD Anderson Cancer Center under the guidance of Bharat Aggarwal[2] and on his return to India, he was reportedly offered a faculty position at the Presidency University which he declined to take up a position at the Centre for DNA Fingerprinting and Diagnostics,[3] where he serves as the head of the Lab of Immunology.[1] His research focus is in the field of immunology and he is known to have carried out work on Cytokine mediated immunoregulation as well as apoptosis in cancer. His studies have been documented by way of a number of articles and ResearchGate, an online repository of scientific articles has listed 115 of them.[4] He also holds a patent for an anticancer agent, jointly developed by him.[5]

The Department of Biotechnology (DBT) of the Government of India awarded him the National Bioscience Award for Career Development, one of the highest Indian science awards in 2009.[6] He resides in Nacharam, a suburb of Hyderabad in the south Indian state of Telangana.[7]

Controversy

In 2012, a Japanese scientist accused Manna of plagiarism with regard to some of the images used by him in one of his articles published in the Journal of Biological Chemistry.[8][9] Two of his articles were immediately retracted,[2][10][11] and some were corrected, leading to seven of his papers being finally retracted.[3][12] He was suspended from his job, after the institute found prima facie evidence against him but he was later reinstated.[8]

References
  1. "CDFD :: Immunology :: Sunil Kumar Manna". www.cdfd.org.in. 21 January 2018. Retrieved 21 January 2018.
  2. "Two retractions for scientist whose work is not fully supported by the available laboratory records - Retraction Watch". Retraction Watch. 4 March 2013. Retrieved 21 January 2018.
  3. "BioTechniques - Seven Retractions for Indian Immunologist". www.biotechniques.com. 5 April 2013. Retrieved 21 January 2018.
  4. "On ResearchGate". On ResearchGate. 20 January 2018. Retrieved 20 January 2018.
  5. "Patent - Anticancer Agent". Patent Gazette. 21 January 2018. Retrieved 21 January 2018.
  6. "Awardees of National Bioscience Awards for Career Development" (PDF). Department of Biotechnology. 2016. Retrieved 20 November 2017.
  7. "Vidwan - Profile Page". vidwan.inflibnet.ac.in. 21 January 2018. Retrieved 21 January 2018.
  8. "Centre for DNA and Fingerprinting Diagnostics scientist in plagiarism controversy". The Times of India. Retrieved 21 January 2018.
  9. "Selection of CDFD director halted". Deccan Chronicle. 27 June 2015. Retrieved 21 January 2018.
  10. Manna, S K; Manna, P; Sarkar, A (May 2013). "Retraction Note to: Retraction: Inhibition of RelA phosphorylation sensitizes chemotherapeutic agents-mediated apoptosis in constitutive NF-kappaB-expressing and chemoresistant cells". Cell Death & Differentiation. 20 (5): 784. doi:10.1038/cdd.2013.18. ISSN 1476-5403. PMC 3619240. PMID 23449392.
  11. Bose, Julie S.; Gangan, Vijay; Prakash, Ravi; Jain, Swatantra Kumar; Manna, Sunil Kumar (28 February 2013). "Retraction: A Dihydrobenzofuran Lignan Induces Cell Death by Modulating Mitochondrial Pathway and G2/M Cell Cycle Arrest". Journal of Medicinal Chemistry. 56 (4): 1787. doi:10.1021/jm4001456. ISSN 0022-2623. PMID 23387381.
  12. "Scientist whose work is "not fully supported by the available laboratory records" to retract 8 more papers - Retraction Watch". Retraction Watch. 5 March 2013. Retrieved 21 January 2018.
  • Gangadharan, Charitha; Thoh, Maikho; Manna, Sunil Kumar (21 January 2018). "Erratum to: RETRACTED ARTICLE: Late phase activation of nuclear transcription factor kappaB by doxorubicin is mediated by interleukin-8 and induction of apoptosis via FasL". Breast Cancer Research and Treatment. 136 (2): 625. doi:10.1007/s10549-012-2293-0.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.